Internal Medicine, Hematology & Oncology · Bridgewater, NJ
NPI
1093949224
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1200 US Highway 22 East, 3rd Fl.
Bridgewater, NJ, 08807
Phone (732) 390-7750
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
160,288 services
Medicare patients, 2024
550
Average age 75
Drug cost, 2024
$5.4M
1,171 prescriptions
Company payments, 2025
$233
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrei M Dobrescu was code J1439 (injection, ferric carboxymaltose, 1 mg), 33,000 times for 30 patients. In total Andrei M Dobrescu billed 160,288 services in 126 codes, and Medicare paid $3.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 33,000 | 30 | $0.87 | $29K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 13,800 | 14 | $44.49 | $614K |
| J0897 Injection, denosumab, 1 mg | Office | 9,060 | 26 | $20.57 | $186K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 3,960 | 11 | $35.20 | $139K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,406 | 24 | $0.09 | $127 |
| 99214 Office E&M - Established | Office | 994 | 339 | $111.75 | $111K |
| 36415 Venipuncture Blood Collection | Office | 950 | 296 | $8.65 | $8,218 |
| 85025 Blood Count | Office | 705 | 230 | $7.56 | $5,329 |
| 96372 Injection Administration | Office | 701 | 124 | $13.11 | $9,188 |
| 85027 Blood Count | Office | 422 | 148 | $6.32 | $2,669 |
| 99232 Hospital E&M - Subsequent | Facility | 420 | 108 | $71.09 | $30K |
| 96413 Chemotherapy Administration | Office | 254 | 57 | $125.23 | $32K |
| 96367 Intravenous Infusion, Hydration | Office | 223 | 46 | $27.04 | $6,031 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 188 | 46 | $0.90 | $169 |
| 99215 Office E&M - Established | Office | 188 | 82 | $159.79 | $30K |
By year: 2022 $1.9M for 105,083 services; 2023 $2.7M for 133,087 services; 2024 $3.0M for 160,288 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 950 | 296 | $8.65 | $8,218 |
| 85025 Blood Count | 705 | 230 | $7.56 | $5,329 |
| 85027 Blood Count | 422 | 148 | $6.32 | $2,669 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrei M Dobrescu prescribed most often to Medicare patients was Eliquis (Apixaban), with 104 prescriptions and refills. In total Andrei M Dobrescu wrote 1,171 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 104 | 169 | 26 | $96K |
| Procrit Epoetin Alfa | 100 | 100 | 15 | $192K |
| Aranesp Darbepoetin Alfa In Polysorbat | 86 | 86 | 13 | $232K |
| Revlimid Lenalidomide | 71 | 71 | Under 11 | $1.1M |
| Warfarin Sodium Generic | 59 | 149 | 11 | $621 |
| Neulasta Pegfilgrastim | 44 | 44 | Under 11 | $339K |
| Brukinsa Zanubrutinib | 30 | 30 | Under 11 | $446K |
| Xtandi Enzalutamide | 25 | 25 | Under 11 | $263K |
| Imbruvica Ibrutinib | 25 | 25 | Under 11 | $371K |
| Xarelto Rivaroxaban | 24 | 48 | Under 11 | $26K |
| Hydroxyurea Generic | 24 | 49 | Under 11 | $660 |
| Abiraterone Acetate Generic | 23 | 23 | Under 11 | $45K |
| Dexamethasone Generic | 22 | 39 | Under 11 | $301 |
| Letrozole Generic | 21 | 41 | Under 11 | $277 |
| Tasigna Nilotinib Hcl | 19 | 19 | Under 11 | $236K |
Brand drugs: 709 claims; generic drugs: 462 claims; opioid claims: 47.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrei M Dobrescu $233 ($233 in general payments such as food, travel and fees) from 9 companies. The largest payer was Gilead Sciences, Inc. with $45.61.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 3 | $45.61 |
| Pfizer Inc. PFE | 2 | $43 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $26.47 |
| Abbvie Inc. ABBV | 1 | $23.04 |
| Genzyme Corporation SNY | 1 | $22.01 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $18.53 |
| Exelixis Inc. EXEL | 1 | $18.5 |
| Blueprint Medicines Corporation SNY | 1 | $18.43 |
| Deciphera Pharmaceuticals Inc. | 1 | $17.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.